Master Alliance Provisions Guide (MAPGuide)

MedinCell – MPP, Malaria Vector Control (mdc-STM/ivermectin formulation) License Agreement

  • Liability | Insurance

12. INDEMNITY AND INSURANCE

[…]

12.3 Insurance. MPP will require the MPP Sub-licensees to purchase and maintain appropriate commercial general liability and product liability insurance as per the terms of the Sub-License Agreement.

Schedule 3. Development Agreement Term Sheet

6. General Insurance Requirement. Throughout the term of the Development Agreement, or during such period as the MedinCell agrees in writing, Development Partner will maintain in full force and effect commercial general liability (CGL) insurance and product liability insurance, with single claim limits consistent with industry standards.

Schedule 4 Commercialisation Agreement Term Sheet

7. General Insurance Requirement: Throughout the term of the Commercialisation Agreement, or during such period as MedinCell agrees in writing, Commercialisation Partner will maintain in full force and effect commercial general liability (CGL) insurance and product liability insurance, with single claim limits consistent with industry standards.

16. Insurance: Within 30 days prior to the first commercial launch by Commercialisation Partner of a Final Product, and each year thereafter for so long as the Commercialisation Agreement is in effect, Commercialisation Partner shall provide to MPP certificates of insurance by insurers acceptable to MPP evidencing comprehensive general liability coverage, including products liability, with a combined limit of no less than 10 million Euros (€10,000,000.00) for bodily injury, including personal injury, and property damage.